866-997-4948(US-Canada Toll Free)

Sequenom, Inc. (SQNM) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Jun 2012

Category :

Surgical Equipment

No. of Pages : 36 Pages


Sequenom, Inc. (Sequenom) is a molecular diagnostic testing and genetics analysis company. It carries out the development and manufacture of DNA analysis systems and related consumables and reagent kits for fine mapping genotyping applications, biomedical research, agricultural applications, molecular medicine and non-invasive prenatal diagnostics research. The companys major product is MassARRAY system, a proprietary nucleic acid analysis platform. Sequenom has wholly owned subsidiaries in Hamburg, Germany; Cambridge, England; Hong Kong; Grand Rapids, Michigan; and Tokyo, Japan. It also has offices in Queensland, Australia and Beijing, China. Sequenom is headquartered in California, the US.

Sequenom seeks to improve the diagnosis of medical conditions and diseases by developing novel nucleic acid based in vitro diagnostic tests. The business strategy of the company envisages building its position in the market place through investing in genetic analysis business by developing and commercializing new biomarker panels; launching and marketing a next-generation MassARRAY system for use in research and diagnostic applications; and expanding its diagnostic offerings through in-licensing, partnering and acquisitions.

This report is a source for data, analysis and actionable intelligence on the Sequenom, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 4
Sequenom, Inc. - Business Description 5
Key Facts 6
Sequenom, Inc. - Major Products and Services 7
Sequenom, Inc. Pipeline Products by Equipment Type 8
Sequenom, Inc. Pipeline Products by Development Stage 10
Sequenom, Inc. Pipeline Products by Therapy Area 11
Sequenom, Inc. Pipeline Products by Trial Phase 13
Sequenom, Inc. Pipeline Products by Milestone Summary 14
AttoSense HPV Test 16
AttoSense HPV Test Product Status 16
AttoSense HPV Test Product Description 16
AttoSense HPV Test Product Milestone 17
AttoSense Lupus Panel 18
AttoSense Lupus Panel Product Status 18
AttoSense Lupus Panel Product Description 18
AttoSense Lupus Panel Product Milestone 19
AttoSense Test - Chronic Kidney Disease 20
AttoSense Test - Chronic Kidney Disease Product Status 20
AttoSense Test - Chronic Kidney Disease Product Description 20
AttoSense Test - Chronic Kidney Disease Product Milestone 20
MaterniT21 21
MaterniT21 Product Status 21
MaterniT21 Product Description 21
MaterniT21 Product Milestone 21
Sensigene Trisomy 21 Test 23
Sensigene Trisomy 21 Test Product Status 23
Sensigene Trisomy 21 Test Product Description 23
Sensigene Trisomy 21 Test Product Milestone 23
Sequenom, Inc. - Key Competitors 25
Sequenom, Inc. - Key Employees 26
Sequenom, Inc. - Key Employee Biographies 27
Sequenom, Inc. - Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 30
Sequenom, Inc., Recent Developments 30
May 29, 2012: Sequenom Reports Recently Released Publication On Sequenom Massarray Research Use System 30
May 17, 2012: Sequenom Provides Update On Agreement With Coventry Health Care 30
May 03, 2012: Sequenom Reports Revenue Of $15m In Q1 2012 30
Apr 17, 2012: Sequenom Extends Multi-Year Supply Agreement With Illumina 31
Mar 07, 2012: Sequenom Reports Revenue Of $55.9m In 2011 31
Feb 22, 2012: Sequenom Files Motion For Preliminary Injunction Against Aria Diagnostics 32
Dec 15, 2011: Sequenom Named To NASDAQ Global Select Market 32
Nov 03, 2011: Sequenom Reports Revenues Of $13.6m In Q3 2011 32
Oct 20, 2011: Sequenom Appoints Suber Huang To Ophthalmology Advisory Board 33
Aug 04, 2011: Sequenom Reports Total Revenues Of $13.3m In Q2 2011 34

Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Table


Sequenom, Inc., Key Facts 1
Sequenom, Inc. Key Pipeline Products by Equipment Type 1
Sequenom, Inc. Key Pipeline Products by Therapy Area 1
Sequenom, Inc. Key Pipeline Products by Development Stage 1
Sequenom, Inc. Key Pipeline Products by Trial Phase 1
Sequenom, Inc., Key Facts 6
Sequenom, Inc., Major Products and Services 7
Sequenom, Inc. Number of Pipeline Products by Equipment Type 8
Sequenom, Inc. Pipeline Products by Equipment Type 9
Sequenom, Inc. Number of Pipeline Products by Development Stage 10
Sequenom, Inc. Pipeline Products by Development Stage 10
Sequenom, Inc. Number of Pipeline Products by Therapy Area 11
Sequenom, Inc. Pipeline Products by Therapy Area 12
Sequenom, Inc. Number of Pipeline Products by Trial Phase 13
Sequenom, Inc. Pipeline Products by Trial Phase 13
Sequenom, Inc. Number of Pipeline Products By Milestone Summary 14
Sequenom, Inc. Pipeline Products by Milestone Summary 15
AttoSense HPV Test - Product Status 16
AttoSense HPV Test - Product Description 16
AttoSense HPV Test - Product Milestone 17
AttoSense Lupus Panel - Product Status 18
AttoSense Lupus Panel - Product Description 18
AttoSense Lupus Panel - Product Milestone 19
AttoSense Test - Chronic Kidney Disease - Product Status 20
AttoSense Test - Chronic Kidney Disease - Product Description 20
AttoSense Test - Chronic Kidney Disease - Product Milestone 20
MaterniT21 - Product Status 21
MaterniT21 - Product Description 21
MaterniT21 - Product Milestone 21
Sensigene Trisomy 21 Test - Product Status 23
Sensigene Trisomy 21 Test - Product Description 23
Sensigene Trisomy 21 Test - Product Milestone 23
Sequenom, Inc., Key Employees 26
Sequenom, Inc., Key Employee Biographies 27
Sequenom, Inc., Other Locations 28
Sequenom, Inc., Subsidiaries 29

List of Chart


Sequenom, Inc. Key Pipeline Products by Equipment Type 1
Sequenom, Inc. Pipeline Products by Equipment Type 8
Sequenom, Inc. Pipeline Products by Development Stage 10
Sequenom, Inc. Pipeline Products by Therapy Area 11
Sequenom, Inc. Pipeline Products by Trial Phase 13
Sequenom, Inc. Pipeline Products by Milestone Summary 14

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *